- $145.19m
- $51.66m
- $138.90m
Quanterix Corp expected to post a loss of 44 cents a share - Earnings Preview
Quanterix Corp expected to post a loss of 44 cents a share - Earnings Preview
Leerink Partners downgrades Quanterix to 'market perform' on Akoya deal risks
Brief: Quanterix And Akoya Biosciences Announce Amended Merger Agreement
Brief: Kent Lake Files Definitive Proxy Statement And Sends Letter To Quanterix Shareholders
Brief: Quanterix Corp - On March 24, Appointed William P. Donnelly As Chairman - SEC Filing
U.S. STOCKS ON THE MOVE-Ultragenyx Pharma, Winnebago, Par Pacific
Impact of NIH job cuts "better than feared" for life sciences firms, Leerink says
Brief: Sera Prognostics appoints Jeff Elliott to board
U.S. RESEARCH ROUNDUP-American Electric Power, Block and Lenz Therapeutics
Quanterix Corp reports results for the quarter ended December 31 - Earnings Summary
Brief: Kent Lake urges Quanterix to address questions regarding Akoya deal
Brief: Kent Lake Nominates Three Highly Qualified, Independent Candidates For Quanterix Board
Brief: Quanterix Highlights Benefits Of Akoya Biosciences Acquisition
U.S. STOCKS ON THE MOVE-Nike, WesBanco, Monday.Com
U.S. STOCKS ON THE MOVE-NXP Semiconductors, Oil stocks, Mobileye
10x Genomics, Quanterix worst-hit if US health agency cuts costs, Leerink says
Brief: Quanterix Provides Update on Financial Performance
U.S. RESEARCH ROUNDUP- Constellation Brands, Merck, WD-40